Table 2.
Cancer site |
Male |
Female |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Age standardised rates (per 100'000) |
Number of cases (per year) |
Change |
Age standardised rates (per 100'000) |
Number of cases (per year) |
Change |
||||||||
2005-2009 | 2015-2019 | 2005-2009 | 2015-2019 | Overall | Due to change in risk | Due to change in population | 2005-2009 | 2015-2019 | 2005-2009 | 2015-2019 | Overall | Due to change in risk | Due to change in population | |
Oral Cavity & Pharynx |
17.15 |
14.53 |
738 |
820 |
11% |
-17% |
28% |
6.37 |
7.04 |
312 |
430 |
38% |
18% |
20% |
Stomach |
10.41 |
7.89 |
474 |
478 |
1% |
-35% |
36% |
5.00 |
4.55 |
306 |
330 |
8% |
-17% |
25% |
Colon, Rectum |
49.34 |
45.76 |
2271 |
2908 |
28% |
-9% |
37% |
30.55 |
28.47 |
1809 |
2084 |
15% |
-9% |
24% |
Lung, Bronchus, Trachea |
54.43 |
45.87 |
2460 |
2791 |
13% |
-22% |
35% |
26.70 |
30.83 |
1380 |
2036 |
48% |
26% |
22% |
Skin Melanoma |
23.81 |
28.54 |
1053 |
1621 |
54% |
25% |
29% |
21.06 |
24.01 |
1007 |
1341 |
33% |
17% |
16% |
Breast |
|
|
|
|
|
|
|
109.88 |
99.33 |
5388 |
5870 |
9% |
-10% |
19% |
Corpus Uteri, Uterus NOS |
|
|
|
|
|
|
|
16.84 |
16.80 |
880 |
1040 |
18% |
-4% |
22% |
Ovary |
|
|
|
|
|
|
|
11.28 |
9.68 |
584 |
622 |
6% |
-15% |
22% |
Prostate |
130.34 |
130.34 |
5900 |
8083 |
37% |
0% |
37% |
|
|
|
|
|
|
|
Bladder |
18.73 |
15.38 |
885 |
1033 |
17% |
-24% |
41% |
4.53 |
4.26 |
289 |
344 |
19% |
-8% |
27% |
Thyroid |
3.55 |
4.29 |
149 |
216 |
45% |
27% |
18% |
9.26 |
11.81 |
406 |
586 |
45% |
32% |
12% |
Non Hodgkin Lymphoma |
17.55 |
19.11 |
779 |
1116 |
43% |
12% |
31% |
12.61 |
14.07 |
688 |
935 |
36% |
14% |
21% |
Other cancers |
120.08 |
118.14 |
5295 |
6845 |
29% |
-1% |
31% |
70.49 |
69.18 |
3864 |
4658 |
21% |
-1% |
22% |
All Cancers except keratinocytic skin cancers | 445.40 | 429.85 | 20005 | 25910 | 30% | -5% | 34% | 324.59 | 320.56 | 16913 | 20359 | 20% | -1% | 21% |